Authors reply: Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

John F Seymour; Mehrdad Mobasher; Arnon P Kater

doi:https://doi.org/10.1056/NEJMc1805135

Authors reply: Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

John F Seymour, Mehrdad Mobasher, Arnon P Kater

Research output: Contribution to journal › Comment/Letter to the editor › Academic

3 Citations (Scopus)

Original language	English
Pages (from-to)	2143-2144
Number of pages	2
Journal	New England journal of medicine
Volume	378
Issue number	22
DOIs	https://doi.org/10.1056/NEJMc1805135
Publication status	Published - 2018

Keywords

Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Rituximab
Sulfonamides

Access to Document

https://doi.org/10.1056/NEJMc1805135

Cite this

@article{9e2fae31ad814aa4b7d2c0586fe48150,

title = "Authors reply: Venetoclax-Rituximab in Chronic Lymphocytic Leukemia",

keywords = "Antineoplastic Agents, Bridged Bicyclo Compounds, Heterocyclic, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Rituximab, Sulfonamides",

author = "Seymour, {John F} and Mehrdad Mobasher and Kater, {Arnon P}",

year = "2018",

doi = "https://doi.org/10.1056/NEJMc1805135",

language = "English",

volume = "378",

pages = "2143--2144",

journal = "New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Authors reply: Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

AU - Seymour, John F

AU - Mobasher, Mehrdad

AU - Kater, Arnon P

PY - 2018

Y1 - 2018

KW - Antineoplastic Agents

KW - Bridged Bicyclo Compounds, Heterocyclic

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell

KW - Rituximab

KW - Sulfonamides

U2 - https://doi.org/10.1056/NEJMc1805135

DO - https://doi.org/10.1056/NEJMc1805135

M3 - Comment/Letter to the editor

C2 - 29847765

SN - 0028-4793

VL - 378

SP - 2143

EP - 2144

JO - New England journal of medicine

JF - New England journal of medicine

IS - 22

ER -